MedTrace Logo

Clinical Trial of YYD302 (Phase3) for Treatment of Osteoarthritis of the Knee

NCT03561779 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 184

Last updated 2021-05-10

No results posted yet for this study

Summary

This is a randomized, double-blind, active-controlled, multi-center, phase 3 study to evaluate the safety and efficacy of intraarticular hyaluronic acid(YYD302) for osteoarthritis of the knee after 12 weeks of treatment and retreatment

Conditions

  • Osteoarthritis, Knee

Interventions

DRUG

YYD302 2ml

YYD302 2ml

DRUG

Active comparator: Synovian Inj.

Active comparator: Synovian Inj.

Sponsors & Collaborators

  • Yooyoung Pharmaceutical Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Chul-Won Ha, M.D · Samsung Medical Center, Department of Internal Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-21
Primary Completion
2019-06-14
Completion
2019-10-04

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03561779 on ClinicalTrials.gov